64 related articles for article (PubMed ID: 19824037)
1. Convergent solid-phase and solution approaches in the synthesis of the cysteine-rich Mdm2 RING finger domain.
Vasileiou Z; Barlos K; Gatos D
J Pept Sci; 2009 Dec; 15(12):824-31. PubMed ID: 19824037
[TBL] [Abstract][Full Text] [Related]
2. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase.
Honda R; Yasuda H
Oncogene; 2000 Mar; 19(11):1473-6. PubMed ID: 10723139
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway.
Hu M; Gu L; Li M; Jeffrey PD; Gu W; Shi Y
PLoS Biol; 2006 Feb; 4(2):e27. PubMed ID: 16402859
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
[TBL] [Abstract][Full Text] [Related]
5. A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination.
Ma J; Martin JD; Zhang H; Auger KR; Ho TF; Kirkpatrick RB; Grooms MH; Johanson KO; Tummino PJ; Copeland RA; Lai Z
Biochemistry; 2006 Aug; 45(30):9238-45. PubMed ID: 16866370
[TBL] [Abstract][Full Text] [Related]
6. MDM2 promotes cell motility and invasiveness through a RING-finger independent mechanism.
Polański R; Warburton HE; Ray-Sinha A; Devling T; Pakula H; Rubbi CP; Vlatković N; Boyd MT
FEBS Lett; 2010 Nov; 584(22):4695-702. PubMed ID: 21034743
[TBL] [Abstract][Full Text] [Related]
7. Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans.
Linke K; Mace PD; Smith CA; Vaux DL; Silke J; Day CL
Cell Death Differ; 2008 May; 15(5):841-8. PubMed ID: 18219319
[TBL] [Abstract][Full Text] [Related]
8. The contribution of the RING finger domain of MDM2 to cell cycle progression.
Argentini M; Barboule N; Wasylyk B
Oncogene; 2000 Aug; 19(34):3849-57. PubMed ID: 10951578
[TBL] [Abstract][Full Text] [Related]
9. Acidic domain is indispensable for MDM2 to negatively regulate the acetylation of p53.
Wang Q; Yang Y; Wang L; Zhang PZ; Yu L
Biochem Biophys Res Commun; 2008 Sep; 374(3):437-41. PubMed ID: 18638452
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Ghosh M; Huang K; Berberich SJ
Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
[TBL] [Abstract][Full Text] [Related]
11. Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation.
Zhang Q; Xiao H; Chai SC; Hoang QQ; Lu H
J Biol Chem; 2011 Nov; 286(44):38264-38274. PubMed ID: 21903592
[TBL] [Abstract][Full Text] [Related]
12. Chemical synthesis of phosphorylated peptides of the carboxy-terminal domain of human p53 by a segment condensation method.
Sakamoto H; Kodama H; Higashimoto Y; Kondo M; Lewis MS; Anderson CW; Appella E; Sakaguchi K
Int J Pept Protein Res; 1996 Nov; 48(5):429-42. PubMed ID: 8956076
[TBL] [Abstract][Full Text] [Related]
13. Crystallographic analysis of an 8-mer p53 peptide analogue complexed with MDM2.
Sakurai K; Schubert C; Kahne D
J Am Chem Soc; 2006 Aug; 128(34):11000-1. PubMed ID: 16925398
[TBL] [Abstract][Full Text] [Related]
14. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
[TBL] [Abstract][Full Text] [Related]
15. Expansion of protein interaction maps by phage peptide display using MDM2 as a prototypical conformationally flexible target protein.
Burch L; Shimizu H; Smith A; Patterson C; Hupp TR
J Mol Biol; 2004 Mar; 337(1):129-45. PubMed ID: 15001357
[TBL] [Abstract][Full Text] [Related]
16. Metal and RNA binding properties of the hdm2 RING finger domain.
Lai Z; Freedman DA; Levine AJ; McLendon GL
Biochemistry; 1998 Dec; 37(48):7005-15. PubMed ID: 9836595
[TBL] [Abstract][Full Text] [Related]
17. An essential function of the extreme C-terminus of MDM2 can be provided by MDMX.
Uldrijan S; Pannekoek WJ; Vousden KH
EMBO J; 2007 Jan; 26(1):102-12. PubMed ID: 17159902
[TBL] [Abstract][Full Text] [Related]
18. Tuning the Binding Affinity and Selectivity of Perfluoroaryl-Stapled Peptides by Cysteine-Editing.
Verhoork SJM; Jennings CE; Rozatian N; Reeks J; Meng J; Corlett EK; Bunglawala F; Noble MEM; Leach AG; Coxon CR
Chemistry; 2019 Jan; 25(1):177-182. PubMed ID: 30255959
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of the human MDM2 p53 binding domain by fusion to a p53 transactivation peptide.
Liu Z; Olejniczak ET; Fesik SW
Protein Expr Purif; 2004 Oct; 37(2):493-8. PubMed ID: 15358376
[TBL] [Abstract][Full Text] [Related]
20. P53 mRNA controls p53 activity by managing Mdm2 functions.
Candeias MM; Malbert-Colas L; Powell DJ; Daskalogianni C; Maslon MM; Naski N; Bourougaa K; Calvo F; Fåhraeus R
Nat Cell Biol; 2008 Sep; 10(9):1098-105. PubMed ID: 19160491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
